Nasal TSLP and periostin in infants with severe bronchiolitis and risk of asthma at 4 years of age

Abstract Background Severe bronchiolitis is often associated with subsequent respiratory morbidity, mainly recurrent wheezing and asthma. However, the underlying immune mechanisms remain unclear. The main goal of this study was to investigate the association of nasal detection of periostin and thymi...

Full description

Bibliographic Details
Main Authors: Maria Luz Garcia-Garcia, Beatriz Sastre, Maria Arroyas, Maite Beato, Patricia Alonso, José Manuel Rodrigo-Muñoz, Victoria Del Pozo, Inmaculada Casas, Cristina Calvo
Format: Article
Language:English
Published: BMC 2023-01-01
Series:Respiratory Research
Subjects:
Online Access:https://doi.org/10.1186/s12931-023-02323-7
_version_ 1811175756200411136
author Maria Luz Garcia-Garcia
Beatriz Sastre
Maria Arroyas
Maite Beato
Patricia Alonso
José Manuel Rodrigo-Muñoz
Victoria Del Pozo
Inmaculada Casas
Cristina Calvo
author_facet Maria Luz Garcia-Garcia
Beatriz Sastre
Maria Arroyas
Maite Beato
Patricia Alonso
José Manuel Rodrigo-Muñoz
Victoria Del Pozo
Inmaculada Casas
Cristina Calvo
author_sort Maria Luz Garcia-Garcia
collection DOAJ
description Abstract Background Severe bronchiolitis is often associated with subsequent respiratory morbidity, mainly recurrent wheezing and asthma. However, the underlying immune mechanisms remain unclear. The main goal of this study was to investigate the association of nasal detection of periostin and thymic stromal lymphopoietin (TSLP) during severe bronchiolitis with the development of asthma at 4 years of age. Methods Observational, longitudinal, post-bronchiolitis, hospital-based, follow-up study. Children hospitalized for bronchiolitis between October/2013 and July/2017, currently aged 4 years, included in a previous study to investigate the nasal airway secretion of TSLP and periostin during bronchiolitis, were included. Parents were contacted by telephone, and were invited to a clinical interview based on a structured questionnaire to obtain information on the respiratory evolution. The ISAAC questionnaire for asthma symptoms for 6–7-year-old children, was also employed. Results A total of 248 children were included (median age 4.4 years). The mean age at admission for bronchiolitis was 3.1 (IQR: 1.5–6.5) months. Overall, 21% had ever been diagnosed with asthma and 37% had wheezed in the last 12 months. Measurable nasal TSLP was detected at admission in 27(11%) cases and periostin in 157(63%). The detection of nasal TSLP was associated with the subsequent prescription of maintenance asthma treatment (p = 0.04), montelukast (p = 0.01), and the combination montelukast/inhaled glucocorticosteroids (p = 0.03). Admissions for asthma tended to be more frequent in children with TSLP detection (p = 0.07). In the multivariate analysis, adjusting for potential confounders, the detection of TSLP remained independently associated with chronic asthma treatment prescription (aOR:2.724; CI 1.051–7.063, p:0.04) and with current asthma (aOR:3.41; CI 1.20–9.66, p:0.02). Nasal detection of periostin was associated with lower frequency of ever use of short-acting beta2-agonists (SABA) (p = 0.04), lower prevalence of current asthma (p = 0.02), less prescription of maintenance asthma treatment in the past 12 months (p = 0.02, respectively). In the multivariate analysis, periostin was associated with lower risk of asthma at 4 years, independently of the atopic status (aOR:0.511 CI 95% 0.284–0.918, p:0.025). Conclusions Our results show a positive correlation between nasal TSLP detection in severe bronchiolitis and the presence of current asthma, prescription of asthma maintenance treatment and respiratory admissions up to the age of 4 years. By contrast, we found a protective association between nasal periostin detection and current asthma at 4 years, ever diagnosis of asthma, maintenance asthma treatment prescription, and respiratory admissions.
first_indexed 2024-04-10T19:41:04Z
format Article
id doaj.art-865e957eda95477aafe3b1699d93826b
institution Directory Open Access Journal
issn 1465-993X
language English
last_indexed 2024-04-10T19:41:04Z
publishDate 2023-01-01
publisher BMC
record_format Article
series Respiratory Research
spelling doaj.art-865e957eda95477aafe3b1699d93826b2023-01-29T12:19:49ZengBMCRespiratory Research1465-993X2023-01-0124111210.1186/s12931-023-02323-7Nasal TSLP and periostin in infants with severe bronchiolitis and risk of asthma at 4 years of ageMaria Luz Garcia-Garcia0Beatriz Sastre1Maria Arroyas2Maite Beato3Patricia Alonso4José Manuel Rodrigo-Muñoz5Victoria Del Pozo6Inmaculada Casas7Cristina Calvo8Pediatrics Department, Hospital Universitario Severo OchoaDepartment of Immunology, IIS-Fundación Jiménez DíazPediatrics Department, Hospital Universitario Severo OchoaPediatrics Department, Hospital Universitario Severo OchoaPediatrics Department, Hospital Universitario Severo OchoaDepartment of Immunology, IIS-Fundación Jiménez DíazDepartment of Immunology, IIS-Fundación Jiménez DíazRespiratory Virus and Influenza Unit, National Microbiology Centre (ISCIII)CIBER de Enfermedades Infecciosas (CIBERINFEC)Abstract Background Severe bronchiolitis is often associated with subsequent respiratory morbidity, mainly recurrent wheezing and asthma. However, the underlying immune mechanisms remain unclear. The main goal of this study was to investigate the association of nasal detection of periostin and thymic stromal lymphopoietin (TSLP) during severe bronchiolitis with the development of asthma at 4 years of age. Methods Observational, longitudinal, post-bronchiolitis, hospital-based, follow-up study. Children hospitalized for bronchiolitis between October/2013 and July/2017, currently aged 4 years, included in a previous study to investigate the nasal airway secretion of TSLP and periostin during bronchiolitis, were included. Parents were contacted by telephone, and were invited to a clinical interview based on a structured questionnaire to obtain information on the respiratory evolution. The ISAAC questionnaire for asthma symptoms for 6–7-year-old children, was also employed. Results A total of 248 children were included (median age 4.4 years). The mean age at admission for bronchiolitis was 3.1 (IQR: 1.5–6.5) months. Overall, 21% had ever been diagnosed with asthma and 37% had wheezed in the last 12 months. Measurable nasal TSLP was detected at admission in 27(11%) cases and periostin in 157(63%). The detection of nasal TSLP was associated with the subsequent prescription of maintenance asthma treatment (p = 0.04), montelukast (p = 0.01), and the combination montelukast/inhaled glucocorticosteroids (p = 0.03). Admissions for asthma tended to be more frequent in children with TSLP detection (p = 0.07). In the multivariate analysis, adjusting for potential confounders, the detection of TSLP remained independently associated with chronic asthma treatment prescription (aOR:2.724; CI 1.051–7.063, p:0.04) and with current asthma (aOR:3.41; CI 1.20–9.66, p:0.02). Nasal detection of periostin was associated with lower frequency of ever use of short-acting beta2-agonists (SABA) (p = 0.04), lower prevalence of current asthma (p = 0.02), less prescription of maintenance asthma treatment in the past 12 months (p = 0.02, respectively). In the multivariate analysis, periostin was associated with lower risk of asthma at 4 years, independently of the atopic status (aOR:0.511 CI 95% 0.284–0.918, p:0.025). Conclusions Our results show a positive correlation between nasal TSLP detection in severe bronchiolitis and the presence of current asthma, prescription of asthma maintenance treatment and respiratory admissions up to the age of 4 years. By contrast, we found a protective association between nasal periostin detection and current asthma at 4 years, ever diagnosis of asthma, maintenance asthma treatment prescription, and respiratory admissions.https://doi.org/10.1186/s12931-023-02323-7BronchiolitisAsthmaRecurrent wheezingPeriostinThymic stromal lymphopoietin (TSLP)Respiratory syncytial virus (RSV)
spellingShingle Maria Luz Garcia-Garcia
Beatriz Sastre
Maria Arroyas
Maite Beato
Patricia Alonso
José Manuel Rodrigo-Muñoz
Victoria Del Pozo
Inmaculada Casas
Cristina Calvo
Nasal TSLP and periostin in infants with severe bronchiolitis and risk of asthma at 4 years of age
Respiratory Research
Bronchiolitis
Asthma
Recurrent wheezing
Periostin
Thymic stromal lymphopoietin (TSLP)
Respiratory syncytial virus (RSV)
title Nasal TSLP and periostin in infants with severe bronchiolitis and risk of asthma at 4 years of age
title_full Nasal TSLP and periostin in infants with severe bronchiolitis and risk of asthma at 4 years of age
title_fullStr Nasal TSLP and periostin in infants with severe bronchiolitis and risk of asthma at 4 years of age
title_full_unstemmed Nasal TSLP and periostin in infants with severe bronchiolitis and risk of asthma at 4 years of age
title_short Nasal TSLP and periostin in infants with severe bronchiolitis and risk of asthma at 4 years of age
title_sort nasal tslp and periostin in infants with severe bronchiolitis and risk of asthma at 4 years of age
topic Bronchiolitis
Asthma
Recurrent wheezing
Periostin
Thymic stromal lymphopoietin (TSLP)
Respiratory syncytial virus (RSV)
url https://doi.org/10.1186/s12931-023-02323-7
work_keys_str_mv AT marialuzgarciagarcia nasaltslpandperiostinininfantswithseverebronchiolitisandriskofasthmaat4yearsofage
AT beatrizsastre nasaltslpandperiostinininfantswithseverebronchiolitisandriskofasthmaat4yearsofage
AT mariaarroyas nasaltslpandperiostinininfantswithseverebronchiolitisandriskofasthmaat4yearsofage
AT maitebeato nasaltslpandperiostinininfantswithseverebronchiolitisandriskofasthmaat4yearsofage
AT patriciaalonso nasaltslpandperiostinininfantswithseverebronchiolitisandriskofasthmaat4yearsofage
AT josemanuelrodrigomunoz nasaltslpandperiostinininfantswithseverebronchiolitisandriskofasthmaat4yearsofage
AT victoriadelpozo nasaltslpandperiostinininfantswithseverebronchiolitisandriskofasthmaat4yearsofage
AT inmaculadacasas nasaltslpandperiostinininfantswithseverebronchiolitisandriskofasthmaat4yearsofage
AT cristinacalvo nasaltslpandperiostinininfantswithseverebronchiolitisandriskofasthmaat4yearsofage